Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, Chabannon C. Calmels B, et al. Among authors: esterni b. Transfusion. 2007 Jul;47(7):1268-75. doi: 10.1111/j.1537-2995.2007.01267.x. Transfusion. 2007. PMID: 17581163
CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation.
Lemarie C, Esterni B, Calmels B, Dazey B, Lapierre V, Lecchi L, Meyer A, Rea D, Thuret I, Chambost H, Curtillet C, Chabannon C, Michel G. Lemarie C, et al. Among authors: esterni b. Bone Marrow Transplant. 2007 Apr;39(8):453-60. doi: 10.1038/sj.bmt.1705618. Epub 2007 Mar 5. Bone Marrow Transplant. 2007. PMID: 17334384
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Blaise D, Farnault L, Faucher C, Marchetti N, Fürst S, El Cheikh J, Ladaique P, Vey N, Bouabdallah R, Stoppa AM, Lemarie C, Calmels B, Prebet T, Castagna L, Chabannon C, Mohty M, Esterni B. Blaise D, et al. Among authors: esterni b. Exp Hematol. 2010 Dec;38(12):1241-50. doi: 10.1016/j.exphem.2010.08.012. Epub 2010 Sep 17. Exp Hematol. 2010. PMID: 20850502
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases.
Crocchiolo R, Esterni B, Castagna L, Fürst S, El-Cheikh J, Devillier R, Granata A, Oudin C, Calmels B, Chabannon C, Bouabdallah R, Vey N, Blaise D. Crocchiolo R, et al. Among authors: esterni b. Cancer. 2013 Mar 1;119(5):986-92. doi: 10.1002/cncr.27858. Epub 2012 Oct 23. Cancer. 2013. PMID: 23096591 Free article.
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Ivanov V, Faucher C, Mohty M, Bilger K, Ladaique P, Sainty D, Arnoulet C, Chabannon C, Vey N, Camerlo J, Bouabdallah R, Viens P, Maraninchi D, Bardou VJ, Esterni B, Blaise D. Ivanov V, et al. Among authors: esterni b. Bone Marrow Transplant. 2005 Nov;36(10):901-6. doi: 10.1038/sj.bmt.1705152. Bone Marrow Transplant. 2005. PMID: 16151421 Clinical Trial.
Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donors.
Castagna L, Crocchiolo R, Furst S, El-cheikh J, Esterni B, Granata A, Stoppa A, Boubdallah R, Coso D, Vey N, Charbonnier A, Lemarie C, Faucher C, Chabannon C, Blaise D. Castagna L, et al. Among authors: esterni b. Bone Marrow Transplant. 2014 Sep;49(9):1246-7. doi: 10.1038/bmt.2014.138. Epub 2014 Jul 7. Bone Marrow Transplant. 2014. PMID: 25000454 No abstract available.
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
Crocchiolo R, Chabannon C, El-Cheikh J, Esterni B, Lemarié C, Fürst S, Castagna L, Bouabdallah R, Ladaique P, Coso D, Schiano JM, Stoppa AM, Rey J, Ivanov V, Aurran T, Faucher C, Blaise D, Calmels B. Crocchiolo R, et al. Among authors: esterni b. Leuk Lymphoma. 2013 Feb;54(2):417-20. doi: 10.3109/10428194.2012.702901. Epub 2012 Jul 9. Leuk Lymphoma. 2013. PMID: 22702654 No abstract available.
Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.
Broussais-Guillaumot F, Coso D, Belmecheri N, Ivanov V, Schiano de Collela JM, Aurran-Schleinitz T, Stoppa AM, Chetaille B, Xerri L, Esterni B, Blaise D, Bouabdallah R. Broussais-Guillaumot F, et al. Among authors: esterni b. Leuk Lymphoma. 2013 Nov;54(11):2392-8. doi: 10.3109/10428194.2013.776680. Epub 2013 Mar 27. Leuk Lymphoma. 2013. PMID: 23410100
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R. Coso D, et al. Among authors: esterni b. Bone Marrow Transplant. 2006 Aug;38(3):217-22. doi: 10.1038/sj.bmt.1705414. Epub 2006 Jun 12. Bone Marrow Transplant. 2006. PMID: 16770316 Clinical Trial.
73 results